FARIDA DANIELS: Open Payments
NPI 1912533316 · AUBURN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,519 in 68 payments from 27 companies in 2025. Trend: 2023 $382 · 2024 $927 · 2025 $1,519
Food & beverage: $1,490Education: $29
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 11 | $217 |
| Merck Sharp & Dohme LLC | 5 | $149 |
| AstraZeneca Pharmaceuticals LP | 5 | $139 |
| ABBVIE INC. | 6 | $135 |
| Exelixis Inc. | 5 | $121 |
| Incyte Corporation | 4 | $101 |
| BeOne Medicines USA, Inc. | 4 | $93 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $60 |
| GlaxoSmithKline, LLC. | 3 | $59 |
| Janssen Biotech, Inc. | 2 | $49 |
Products named: VRAYLAR, CABOMETYX, IBRANCE, KEYTRUDA, JAKAFI, BRUKINSA, Tecentriq, JEMPERLI.
Industry payments across GA — which companies pay providers there.
